Kaynakça
Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet 2016;388:2039-52.
Kozanoğlu E. Gut hastalığı. In: Bodur H, Ataman Ş, editors. Romatoloji e-Kitap. İstanbul: Türkiye Romatoloji Derneği; 2019. p. 2-26. Available from: https://www.trasdromatolojiekitap.org/icindekiler.php?id=114
McLean L, Dalbeth N. Etiology and pathogenesis of gout. In: Hochberg MC, Silman AJ, Smolen JS et al., editors. Rheumatology. 6th ed. Philadelphia: Mosby Elsevier; 2015. P. 1555-68.
Ministry of Health of the Republic of Türkiye. Favipiravir 200 mg Tablet – Information for Drugs Used in the Treatment of COVID-19 (SARS-CoV-2 Infection). Ankara: Ministry of Health; 2021. Available from: khgmstokyonetimidb.saglik.gov.tr (Accessed Feb 2026).
Ministry of Health of the Republic of Türkiye, General Directorate of Public Health. COVID-19 (SARS-CoV-2 Infection) Adult Patient Treatment Guideline. Ankara: Ministry of Health; 2020. Available from: https://www.ekmud.org.tr/files/uploads/files/Saglik-Bakanligi-COVID-19-rehberi-23032020.pdf (Accessed Feb 2026).
Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015;74:1789-98.
Babaoğlu H. Türkiye Romatoloji Derneği Romatoloji Uzmanları için Koronavirüs (Covid-19) salgını sırasında hastalık yönetimi önerileri. J Turk Soc Rheumatol 2020;12:1-2.
FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72:744-60.
Jatuworapruk K, Satpanich P, Robinson PC, Grainger R. Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: a multicenter retrospective cohort study. J Rheumatol. 2023;50:556-63.
Robinson PC, Kempe S, Tebbutt I, et al. Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site. Int J Rheum Dis. 2017;20:779-84.
López-González MD, Peral-Garrido ML, Calabuig I, et al. Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2021;80:e58.
Kim JH, Kwon MJ, Choi HG, et al. Changes in the mean incidence and variance of orthopedic diseases before and during the COVID-19 pandemic in Korea: a retrospective study. BMC Musculoskelet Disord. 2023;24:540.
Kihara M, Sugihara T, Asano J, et al. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Clin Rheumatol. 2022;41:3661-73.
COVID-19 Global Rheumatology Alliance. The COVID-19 Global Rheumatology Alliance (GRA). Available from: https://rheum-covid.org/ (Accessed Feb 2026).
Hase R, Kurata R, Ishida K, et al. Acute gouty arthritis during favipiravir treatment for coronavirus disease 2019. Intern Med. 2020;59:2327-9.
Mongkolporn A, Satpanich P, Grainger R, Jatuworapruk K. GOUT-36 prediction rule is sensitive in predicting gout flare during COVID-19 hospitalization. Int J Rheum Dis. 2024;27:e15010.
